Ligatürle İndüklenen Rat Periodontitis Modelinde Sistemik Darbepoetin Alfa Uygulamasının Alveolar Kemik Kaybı Üzerine Etkisinin Morfometrik Değerlendirilmesi

Öz

Amaç: Bu deneysel çalışmada, ligatür ile oluşturulan sıçan periodontitis modelinde sistemik darbepoetin alfa uygulamasının alveolar kemik kaybı üzerindeki etkisinin morfometrik yöntemle değerlendirilmesi amaçlandı. Gereç ve Yöntem: Çalışmaya elli erişkin erkek Sprague–Dawley sıçan dahil edildi ve hayvanlar rastgele beş gruba ayrıldı (n=10): Kontrol, Kontrol + darbepoetin alfa (0,25 µg/kg/gün), Periodontitis, Periodontitis + darbepoetin alfa (0,1 µg/kg/gün) ve Periodontitis + darbepoetin alfa (0,25 µg/kg/gün). Deneysel periodontitis, mandibular birinci molar dişlerin çevresine ipek ligatür yerleştirilerek oluşturuldu. Darbepoetin alfa deney süresince 11 gün boyunca intraperitoneal olarak uygulandı. Deney sonunda mandibulalar çıkarıldı ve alveolar kemik kaybı, stereomikroskop altında mine-sement sınırı ile alveolar kemik kreti arasındaki doğrusal mesafenin ölçülmesiyle morfometrik olarak değerlendirildi. İstatistiksel anlamlılık düzeyi p<0,05 olarak kabul edildi. Bulgular: Periodontitis grubunda alveolar kemik kaybı, kontrol gruplarına kıyasla anlamlı derecede yüksekti (p<0,05). Sistemik darbepoetin alfa uygulanan periodontitis gruplarında alveolar kemik kaybı, tedavi uygulanmayan periodontitis grubuna göre anlamlı düzeyde azaldı (p<0,05). Ortalama alveolar kemik kaybı; Kontrol grubunda 0,42 mm, Kontrol + darbepoetin alfa grubunda 0,44 mm, Periodontitis grubunda 1,27 mm, Periodontitis + 0,1 µg/kg/gün darbepoetin alfa grubunda 0,79 mm ve Periodontitis + 0,25 µg/kg/gün darbepoetin alfa grubunda 0,77 mm olarak belirlendi. Darbepoetin alfa uygulanan iki periodontitis grubu arasında alveolar kemik kaybı açısından istatistiksel olarak anlamlı bir fark saptanmadı (p>0,05). Sonuç: Sistemik darbepoetin alfa, ligatür ile oluşturulan deneysel periodontitis modelinde alveolar kemik kaybını anlamlı düzeyde azaltmıştır. Her iki doz benzer koruyucu etki göstermiştir. Bulguların doğrulanması için ileri deneysel ve klinik çalışmalara gereksinim vardır.

Anahtar Kelimeler

• Alveolar kemik kaybı
• darbepoetin alfa
• deneysel periodontitis
• morfometrik analiz
• sıçan

Destekleyen Kurum

Eskişehir Osmangazi Üniversitesi Bilimsel Araştırma Projeleri Komisyonu

Proje Numarası

2020-3073

Morphometric Assessment of Alveolar Bone Loss Following Systemic Darbepoetin Alfa Administration in a Rat Model of Ligature-Induced Periodontitis

Öz

Aim: This experimental study investigated whether systemic administration of darbepoetin alfa could reduce alveolar bone loss in a rat model of ligature-induced periodontitis through morphometric evaluation. Materials and Methods: Fifty adult male Sprague–Dawley rats were randomly allocated to five experimental groups (n = 10): Control, Control receiving darbepoetin alfa (0.25 µg/kg/day), Periodontitis, Periodontitis treated with darbepoetin alfa (0.1 µg/kg/day), and Periodontitis treated with darbepoetin alfa (0.25 µg/kg/day). Experimental periodontitis was established by placing silk ligatures around the mandibular first molars. Darbepoetin alfa was administered intraperitoneally once daily throughout the 11-day experimental period. Following euthanasia, morphometric assessment of alveolar bone loss was performed by determining the linear distance between the cementoenamel junction and the alveolar bone crest using stereomicroscopic images. Results: Ligature placement resulted in a marked increase in alveolar bone loss compared with the healthy control groups (p < 0.05). Administration of darbepoetin alfa significantly limited bone loss in both treatment groups relative to untreated periodontitis (p < 0.05). Mean alveolar bone loss values were 0.42 mm in the Control group, 0.44 mm in the Control + darbepoetin alfa group, 1.27 mm in the Periodontitis group, 0.79 mm in the Periodontitis + 0.1 µg/kg/day group, and 0.77 mm in the Periodontitis + 0.25 µg/kg/day group. No statistically significant difference was identified between the two darbepoetin alfa dosage regimens (p > 0.05). Conclusion: Systemic administration of darbepoetin alfa significantly reduced alveolar bone loss in a ligature-induced rat model of periodontitis. Both treatment doses demonstrated comparable protective effects. Further experimental and clinical studies are needed to confirm these findings.

Anahtar Kelimeler

• Alveolar bone loss
• darbepoetin alfa
• experimental periodontitis
• morphometric analysis
• rat

Destekleyen Kurum

Eskişehir Osmangazi Üniversitesi Bilimsel Araştırma Projeleri

Proje Numarası

2020-3073

Kaynakça

1. 1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809-1820.
2. 2. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038.
3. 3. Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426-440.
4. 4. Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice. J Immunol Methods. 2013;394(1-2):49-54.
5. 5. de Molon RS, Park CH, Jin Q, et al. Characterization of ligature-induced experimental periodontitis. Microsc Res Tech. 2018;81(12):1412-1421.
6. 6. Brines M, Cerami A. The receptor that tames the innate immune response. Mol Med. 2012;18:486-496.
7. 7. Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother. 2013;40(5):302-309.
8. 8. Zakaria MF, Sonoda S, Kato H, et al. Erythropoietin receptor signal is crucial for periodontal ligament stem cell-based tissue reconstruction in periodontal disease. Sci Rep. 2024;14:6719.

9. 9. Ozkurt M, Uzuner K, Erkasap N, Kus G, Ozyurt R, Uysal O, Akyazi I, Kutlay O. Erythropoietin Protects the Kidney by Regulating the Effect of TNF-alpha in L-NAME-Induced Hypertensive Rats. Kidney Blood Press Res 2018;43(3):807-19.
10. 10. Toker H, Ozdemir H, Eren K, Ozer H, Sahin G. N-acetylcysteine, a thiol antioxidant, decreases alveolar bone loss in experimental periodontitis in rats. J Periodontol 2009;80(4):672-8
11. 11. Bahlmann FH, Song R, Boehm SM, et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation. 2004;110(8):1006-1012.
12. 12. Coccia MA, Cooke K, Stoney G, et al. Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic inflammatory disease in a rodent model. Exp Hematol. 2001;29(10):1201-1209.
13. 13. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol. 2008;35(2 Suppl):89-105.
14. 14. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8(7):481-490.
15. 15. Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res. 2011;90(2):143-153.
16. 16. Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res. 2010;89(12):1349-1363.
17. 17. Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol. 2008;79(8 Suppl):1601-1608.
18. 18. Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to control the infection. Periodontol 2000. 2017;75(1):317-329.
19. 19. Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unifying historical and contemporary concepts. Periodontol 2000. 2013;62(1):203-217.